Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico

Paul Schloesser

Associate Editor

A small California biotech emerged from stealth last year to go after drug discovery’s “data problem,” and now the AI outfit has announced its first …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

Months af­ter adding $60M to cof­fers, AI start­up Ter­ray nabs dis­cov­ery pact with Google's Cal­i­co

Associate Editor

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico